Protective role of metallothionein on DNA damage in rat kidney caused by cis-diamminedichloroplatinum

Pharmacology and Toxicology

Volumn 86, Issue 6, 2000, Pages 276-282

  Hosokawa, Toshiyuki ^a   Okabe, Masashi ^a   Saito, Shigeru ^a   Saito, Takeshi ^b   Kurasaki, Masaaki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; COPPER; METALLOTHIONEIN; PLATINUM; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA DAMAGE; KIDNEY CORTEX; MALE; NEPHROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; TISSUE SPECIFICITY;

EID: 0034045706     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0901-9928.2000.860606.x     Document Type: Article

References (36)

1. Aggarwal, S. K.: A Histochemical approach to the mechanism of action of cisplatin and its analogues. J. Histochem. Cytochem. 1993, 41, 1053-1073.
2. Bauman, J. W., J. Liu, Y. P. Liu & C.D. Klaassen: Increase in metallothionein produced by chemicals that induce oxidative stress. Toxicol. Appl. Pharmacol. 1991, 110, 347-354.
3. Blisard, K. S., D. A. Harrington, D. A. Long & J. E. Jackson: Relative lack of toxicity of transplatin compared with cisplatin in rodents. J. Comp. Pathol. 1991, 105, 367-375.
4. Courjault, F., D. Leroy, L. Coquery & H. Toutain: Platinum complex-induced dysfunction of cultured renal proximal tubule cells. A comparative study of carboplatin and transplatin with cisplatin. Arch. Toxicol. 1993, 67, 338-346.
5. DeWoskin, R. S. & J. E. Riviere: Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna. Toxicol. Appl. Pharmacol. 1992, 112, 182-189.
6. Gavrieli, Y., Y. Sherman & S. A. Ben-Sasson: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol. 1992, 119, 493-501.
7. Hanada, T., H. Isobe, T. Saito, S. Ogura, H. Takekawa, K. Yamazaki, Y. Tokuchi & Y. Kawakami: Intracellular accumulation of thallium as a makar of cisplatin cytotoxicity in nonamall cell lung carcinoma: An application of inductively coupled plasma mass spectrometry. Cancer 1998a, 83, 930-935.
8. Hanada, T., H. Isobe, T. Saito, S. Ogura, K. Saito & Y. Kawakami: Inductively coupled plasma mass spectrometry for the determination of platinum accumulation in human non-small cell lung cancer cell lines. Int. J. Clin. Oncol. 1998b, 3, 98-101.
9. Kurasaki, M., M. Okabe, S. Saito & M. Suzuki-Kurasaki: Copper metabolism in the kidney of rats administered copper and copper-metallothionein. Amer. J. Physiol. 1998, 274, F783-F790.
10. Kägi, J. H. R.: Evolution, structure and chemical activity of class I metallothionein: An overview. In Metallothionein III. Eds.: K. T. Suzuki, N. Imura and M. Kimura. Birkhäuser Verlag, Basel, Switzerland, 1993, pp. 29-55.
11. Kägi, J. H. R. & Y. Kojima: Chemistry and biochemistry of metallothionein. Experientia suppl. 1987, 52, 25-61.
12. Liu, J., Y. Liu, S. S. Habeebu & C.D. Klaassen: Metallothionein (MT)-null mice are sensitive to cisplatin-induced hepatotoxicity. Toxicol. Appl. Pharmacol. 1998, 149, 24-31.
13. Madias, N. E. & J. Harrington: Platinum nephrotoxicity. Amer. J. Med. 1978, 65, 307-314.
14. Mello, J. A., S. J. Lippard & J. M. Essigmann: DNA adducts of cis-diamminedichloroplatinum(II) and its trans isomer inhibit RNA polymerase II differentially in vivo. Biochemistry 1995, 34, 14783-14791.
15. Naganuma, A., M. Satoh & N. Imura: Protective effect of metallothionein inducing metals on lethal toxicity of cis-diamminedichloroplatinum in mice. Toxicol Lett. 1985, 24, 203-207.
16. Naganuma, A., M. Satoh & N. Imura: Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice. Cancer Res. 1987, 47, 983-987.
17. Nakamura, M., S. Imaoka, E. Tanaka, S. Misawa & Y. Funae: Cis-diamminedichloroplatinum induces peroxisomes as well as CYP4A1 in rat kidney. Res. Commun. Mol. Pathol. Pharmacol. 1998, 99, 23-32.
18. Nordberg, M. & G. F. Nordberg: On the role of metallothionein in cadmium induced renal toxicity. Experientia suppl. 1987, 52, 669-675.
19. Okabe, M., C. Nyakas, B. Buwalda & P. G. M. Luiten: In situ blotting: a novel method for direct transfer of native proteins from sectioned tissue to blotting membrane: procedure and some applications. J. Histochem. Cytochem. 1993, 41, 927-934.
20. Okabe, M., K. Nakayama, M. Kurasaki, F. Yamasaki, K. Aoyagi, O. Yamanoshita, S. Sato, T. Okui, T. Ohyama & N. Kasai: Direct visualization of copper-metallothionein in LEC rat kidneys: Application of auto-fluorescence signal of copper-thiolate cluster. J. Histochem. Cytochem. 1996, 44, 865-873.
21. Okabe, M., T. Hosokawa, S. Saito, T. Saito & M. Kurasaki: Histochemical studies on renal copper metallothionein using confocal laser microscopy. Trace Elem. Electrolytes 1999, 16, 61-66.
22. Reed, K. J.: The mechanism of action of platinum anti-tumor drugs. Pure. Appl. Chem. 1987, 59, 181-192.
23. Safirstein, R., J. Winston, D. Moel, S. Dikman & J. Guttenplan: Cisplatin nephrotoxicity: insights into mechanism. Int. J. Androl. 1987, 10, 325-346.
24. Saito, S., M. Okabe & M. Kurasaki: Localization of renal Cu-binding metallothionein induced by Au injection into rats. Biochim. Biophys. Acta 1997, 1335, 353-358.
25. Sato, P. H., J. M. Rosenberg & R. I. Sato: Differences in the inhibition of translation by cisplatin, transplatin, and certain related compounds. Biochem. Pharmacol. 1996, 52, 1895-1902.
26. Satoh, M., A. Naganuma & N. Imura: Metallothionein induction prevents toxic side effects of cisplatin and adriamycin used in combination. Cancer Chem. Pharmacol. 1988, 21, 176-178.
27. Satoh, M., D. M. Kloth, S. A. Kadhim, J. L. Chin, A. Naganuma, N. Imura & M. G. Cherian: Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis. Cancer. Res. 1993a, 53, 1829-1832.
28. Satoh, M., T. Tsuchiya, Y. Kumada, A. Naganuma & N. Imura: Protection against lethal toxicity of various anticancer drugs by preinduction of metallothionein synthesis in mice. J. Trace. Elem. Exp. Med. 1993b, 6, 41-44.
29. Satoh, M., Y. Aoki & C. Tohyama: Protective role of metallothionein in renal toxicity of cisplatinum. Cancer Chem. Pharmacol. 1997, 40, 358-362.
30. Suzuki, C. A. M. & M. G. Cherian: The interactions of cis-diamminedichloroplatinum with metallothionein and glutathione in rat liver and kidney. Toxicology 1990, 64, 113-127.
31. Suzuki-Kurasaki, M., M. Okabe & M. Kurasaki: Copper-metallothionein in the kidney of Macular mice: a model for Menkes disease. J. Histochem. Cytochem. 1997, 45, 1493-1501.
32. Von Hoff, D. D., R. Schilsky, C. M. Reihert, R. L. Reddick, M. Reozencweig, R. C. Young & F. M. Muggia: Toxic effects of cis-dichlorodiammineplatinum(II) in man. Cancer Treat. Rep. 1979, 63, 1527-1531.
33. Zalups R. K. & M. G. Cherian: Renal metallothionein metabolism after a reduction of renal mass. I. Effect of unilateral nephrectomy and compensatory renal growth on basal and metal-induced renal metallothionein metabolism. Toxicology 1992a, 71, 83-102.
34. Zalups R. K. & M. G. Cherian: Renal metallothionein metabolism after a reduction of renal mass. II. Effect of zinc pretratment on the renal toxicity and intrarenal accumulation of inorganic mercury. Toxicology 1992b, 71, 103-117.
35. Zelazowski, A. J., J. S. Garvey & J. D. Hoeschele: In vivo and in vitro binding of platinum to metallothionein. Arch. Biochem. Biophys. 1984, 229, 246-252.
36. Zhang, B., H. Huang & W. Tang: Interaction of cis-and trans-diamminedichloroplatinum with metallothionein In vivo. J. Inorg. Biochem. 1995, 58, 1-8.